Form 4: Accelerate Diagnostics Director John Patience Acquires 200,000 Shares in Private Transaction

Director John Patience of Accelerate Diagnostics, Inc. purchased 200,000 shares of common stock in a private transaction on December 3, 2024.

Summary

• John Patience, a director at Accelerate Diagnostics, Inc., acquired 200,000 shares of common stock on December 3, 2024.
• The shares were purchased at a price of $1.57 per share.
• This transaction was a private purchase from Jack Schuler, another member of the company's board of directors.
• Following the transaction, Mr. Patience beneficially owns a total of 653,224 shares through a living trust, 3,941 shares through an IRA, and 214,046 shares through Patience Enterprises LP.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as it reflects a director's increased investment in the company, but it is a routine transaction.

Positives

• The purchase demonstrates a director's confidence in the company's future prospects.
• The acquisition increases the director's stake in the company, aligning his interests with those of other shareholders.

Industry Context

This type of transaction is common among company directors and officers, and is often seen as a sign of confidence in the company's future. It is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Insider transactions are a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• The size of the transaction is not unusual for a director of a company of this size.
• Similar transactions can be seen in other companies in the diagnostics and healthcare sectors, such as BioMerieux and Danaher, where directors and officers regularly adjust their holdings.

Related Party Transactions

• The transaction was a private purchase from Jack Schuler, a member of the issuer's board of directors, which is a related party transaction.

Stakeholder Impact

• The transaction may be viewed positively by shareholders as it indicates a director's confidence in the company.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Accelerate Diagnostics, John Patience, insider trading, share purchase, private transaction, board of directors, common stock, beneficial ownership